Medicines News | finanzen.ch

Medicines Aktie VALOR 1114748 / ISIN US5846881051

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

10.09.25	U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China (New York Times)
07.09.25	FDA Tightens Grip On Safe Weight Loss Drugs, WHO Adds Them To Essential Medicines List (Benzinga)
29.08.25	BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients (Benzinga)
23.08.25	Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Them (New York Times)
07.08.25	BeOne Medicines (ONC) Q2 EPS Soars 924% (MotleyFool)
30.07.25	GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth (Benzinga)
28.07.25	Trump’s Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions (New York Times)
16.07.25	Deep Dive Into BeOne Medicines Stock: Analyst Perspectives (9 Ratings) (Benzinga)
27.06.25	What 8 Analyst Ratings Have To Say About BeOne Medicines (Benzinga)
24.06.25	Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds (Benzinga)
02.06.25	Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket (Benzinga)
07.05.25	Praxis Precision Medicines 'A Diversified Player In Epilepsy Market,' Analyst Sees Over 100% Stock Upside (Benzinga)
06.05.25	Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns (Benzinga)
30.04.25	Blueprint Medicines Earnings Preview (Benzinga)
28.04.25	What Analysts Are Saying About Blueprint Medicines Stock (Benzinga)
28.04.25	Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday? (Benzinga)
17.04.25	EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity (Benzinga)
17.04.25	EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity (Benzinga)
08.04.25	Breaking Down Blueprint Medicines: 14 Analysts Share Their Views (Benzinga)
20.03.25	The Analyst Verdict: Blueprint Medicines In The Eyes Of 14 Experts (Benzinga)
17.03.25	This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday (Benzinga)
03.03.25	13 Analysts Assess Blueprint Medicines: What You Need To Know (Benzinga)
26.02.25	AstraZeneca's Investigational Cancer Drug Shows First-Line Benefit In Combination With Widely Cancer Medicines (Benzinga)
13.02.25	Breaking Down Blueprint Medicines: 10 Analysts Share Their Views (Benzinga)
06.02.25	Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines (Benzinga)
05.02.25	Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines (Benzinga)
02.01.25	What Analysts Are Saying About Blueprint Medicines Stock (Benzinga)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	88.74	0.20 %	K V
Swisscom	570.50	0.09 %	K V
Geberit	586.20	-0.10 %	K V
Holcim	68.26	-0.15 %	K V
Nestle	71.35	-0.38 %	K V
UBS Group	33.03	-1.49 %	K V
Roche Hldg G	261.20	-1.51 %	K V
Alcon	59.80	-1.55 %	K V
Lonza Grp	529.80	-1.71 %	K V
Part Grp Hldg	1’052.00	-2.59 %	K V